Rankings
▼
Calendar
TECX
Tectonic Therapeutic, Inc.
$634M
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$184,000
Operating Income
-$17M
Net Income
-$16M
EPS (Diluted)
$-8.08
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$12M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$133M
Total Liabilities
$11M
Stockholders' Equity
$122M
Cash & Equivalents
$126M
← FY 2018
All Quarters
Q1 2019 →
TECX Q4 2018 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena
